Norwegian biotechnology has been thrown a lifeline after the country’s government made explicit provision for life sciences and innovation research within the NOK20bn ($2.87bn) stimulus package unveiled on Monday.

The biotechnology component of the stimulus, valued at just under £300m (€318m, $418m) will prevent half of the company’s biotechnology groups from going bankrupt.